Genzyme Renal Division President John Butler: An Interview With “The Pink Sheet” DAILY
This article was originally published in The Pink Sheet Daily
Executive Summary
Butler speaks with the DAILY about the Renvela launch, plans for a next-generation phosphate binder and other candidates in the biotech’s renal pipeline.